June 18, 2024

Alzheon, a clinical-stage biopharmaceutical company based in Framingham, MA, has raised $100 million in Series E funding. The funding round was led by…

May 20, 2024

Johnson & Johnson has entered into a definitive agreement to acquire Proteologix, a Redwood City, California-based biotechnology company specializing in bispecific antibodies for…